Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HBMD Insider Trading

HBMD | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HBMD provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-01-08 19:03 2019-01-08 Coffman George C. Officer - EVP-CFO BUY $12.87 400 $5,148 67,040 +0.6%
2019-01-08 19:51 2019-01-08 TURNER FRANK K JR Officer - EVP-CLO BUY $12.87 23 $296 6,023 +0.4%
2018-09-25 18:19 2018-09-24 Arnold Richard G. Director BUY $17.50 2,815 $49,263 134,167 +2.1%
2018-09-18 18:43 2018-09-17 O NEILL THOMAS P Director BUY $18.60 750 $13,950 24,861 +3.1%
2018-09-14 17:45 2018-09-13 Staton Donna Hill Director BUY $18.45 545 $10,055 14,571 +3.9%
2018-09-13 17:03 2018-09-06 Arnold Richard G. Director BUY $17.26 1,493 $25,769 130,284 +1.2%
2018-08-24 16:54 2018-08-23 Kunisch Robert D Jr. Director, Officer - President BUY $17.16 5,000 $85,800 2,500 +100.0%
2018-08-09 17:40 2018-08-08 Smith Robert W. Jr. Director BUY $16.62 2,000 $33,240 40,178 +5.2%
2018-08-09 14:55 2018-08-08 Keenan John J. Director BUY $16.66 2,000 $33,320 9,645 +26.2%
2018-08-07 00:01 2018-08-06 Schwabe Charles E. Officer - EVP-CRO BUY $16.30 250 $4,075 50,056 +0.5%
2018-08-06 20:54 2018-08-06 Scully Mary Ann Director, Officer - Chairperson/CEO BUY $16.54 600 $9,924 140,812 +0.4%
2018-07-31 23:20 2018-07-31 Smith Robert W. Jr. Director BUY $16.18 2,500 $40,450 38,178 +7.0%
2018-02-15 16:45 2018-02-14 Smith Robert W. Jr. Director BUY $18.43 1,300 $23,959 35,678 +3.8%
2017-12-19 22:16 2017-12-19 Hartson Robert J. Director SELL $23.15 7,500 $173,625 159,276 -4.5%
2017-09-19 16:48 2017-09-19 Poynot Steven Officer - EVP SELL $20.46 1,334 $27,289 0 -100.0%
2017-08-23 21:12 2017-06-22 Witty James D Officer - EVP BUY $19.40 300 $5,819 5,984 +5.3%
2017-02-08 20:18 2017-02-07 McGraw Karen D Director BUY $18.12 500 $9,060 4,206 +13.5%
2017-02-03 19:51 2017-02-02 Staton Donna Hill Director BUY $15.00 3,000 $45,000 12,318 +32.2%
2017-02-03 19:35 2017-02-02 Hartson Robert J. Director BUY $15.00 10,000 $150,000 163,768 +6.5%
2017-02-03 19:12 2017-02-02 Scully Mary Ann Director, Officer - CEO BUY $15.00 2,000 $30,000 129,020 +1.6%
2017-02-03 19:08 2017-02-02 Smith Robert W. Jr. Director BUY $15.00 4,500 $67,500 33,070 +15.8%
2017-02-03 19:03 2017-02-02 Witty James D Officer - EVP BUY $15.00 1,350 $20,250 2,350 +135.0%
2017-02-03 18:59 2017-02-01 Keenan John J. Director BUY $15.00 2,000 $30,000 6,337 +46.1%
2017-02-03 18:51 2017-02-02 Arnold Richard G. Director BUY $15.00 16,000 $240,000 124,173 +14.8%
2017-02-03 18:43 2017-02-02 Lundeen Kenneth C. Director BUY $15.00 1,000 $15,000 134,771 +0.7%
2017-02-03 19:16 2017-02-02 Morgan Richard Joseph Director BUY $15.00 3,333 $49,995 6,258 +113.9%
2017-02-03 18:55 2017-02-02 O NEILL THOMAS P Director BUY $15.00 3,333 $49,995 22,403 +17.5%
2017-02-03 19:22 2017-02-02 ALTIERI ROBERT A Officer - EVP BUY $15.00 1,600 $24,000 12,267 +15.0%
2017-02-03 19:25 2017-02-02 BOZEL GARY R Director BUY $15.00 4,000 $60,000 48,273 +9.0%
2016-12-01 21:14 2016-12-01 Staton Donna Hill Director BUY $14.64 675 $9,882 9,318 +7.8%
2016-10-31 21:30 2016-10-31 CLARK ANDREW E Director SELL $13.40 16,172 $216,705 33,426 -32.6%
2016-07-15 18:57 2016-07-15 BOZEL GARY R Director SELL $0.00 125 $0 44,149 -0.3%
2016-05-17 15:38 2016-05-16 Witty James D Officer - EVP BUY $12.95 1,000 $12,950 1,000 +100.0%
2016-05-05 23:49 2016-05-05 McGraw Karen D Director BUY $12.97 1,541 $19,987 3,457 +80.4%
2016-04-07 22:07 2012-07-23 CLARK ANDREW E Director BUY $7.30 5,190 $37,887 48,524 +12.0%
2015-06-18 22:09 2015-06-16 Keenan John J. Director BUY $13.75 1,600 $22,000 3,597 +80.1%
2015-05-28 23:59 2015-05-27 McGraw Karen D Director BUY $14.28 350 $4,998 350 +100.0%
2015-05-22 00:46 2015-05-21 Finnegan Dennis Officer - EVP BUY $13.96 1,000 $13,955 1,000 +100.0%
2015-05-15 01:37 2015-05-14 Meyers Robert N. Director BUY $10.45 458 $4,786 41,037 +1.1%
2015-03-23 23:30 2015-03-20 Staton Donna Hill Director BUY $13.86 700 $9,705 7,643 +10.1%
2015-03-12 21:33 2015-03-12 Morgan Richard Joseph Director BUY $13.90 1,800 $25,020 1,800 +100.0%
2014-09-11 22:11 2014-09-09 Keenan John J. Director BUY $10.34 272 $2,812 1,000 +37.4%
2014-08-26 18:29 2014-08-26 Keenan John J. Director BUY $10.00 78 $780 728 +12.0%
2014-08-18 19:40 2014-08-14 Keenan John J. Director BUY $10.00 650 $6,500 650 +100.0%
2013-08-15 23:27 2013-08-14 Smith Robert W. Jr. Director BUY $8.20 2,756 $22,599 20,000 +16.0%
2013-08-15 23:11 2013-08-13 Hartson Robert J. Director BUY $8.30 1,000 $8,300 140,099 +0.7%
2013-08-14 20:26 2013-08-13 Smith Robert W. Jr. Director BUY $8.25 1,344 $11,088 17,244 +8.5%
2013-08-05 18:49 2013-08-02 Smith Robert W. Jr. Director BUY $8.25 400 $3,300 15,900 +2.6%
2013-08-01 19:22 2013-07-31 Smith Robert W. Jr. Director BUY $8.25 500 $4,125 15,500 +3.3%
2013-03-19 21:19 2013-03-15 Hartson Robert J. Director BUY $6.50 36 $234 139,099 +0.0%
SHOW ENTRIES

How to Interpret $HBMD Trades

Not every insider transaction in HBMD is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HBMD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HBMD

Insider activity data for HBMD is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HBMD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.